Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective
暂无分享,去创建一个
B. Salehi | M. Iriti | J. Sharifi‐Rad | M. Martorell | N. Martins | R. Pezzani | S. Vitalini | F. Zúñiga | Javad Sharifi‐Rad
[1] B. Salehi,et al. The therapeutic potential of curcumin: A review of clinical trials. , 2019, European journal of medicinal chemistry.
[2] B. Salehi,et al. Nepeta species: From farm to food applications and phytotherapy , 2018, Trends in Food Science & Technology.
[3] A. Mishra,et al. Resveratrol: A Double-Edged Sword in Health Benefits , 2018, Biomedicines.
[4] B. Salehi,et al. Phytochemicals in Helicobacter pylori Infections: What Are We Doing Now? , 2018, International journal of molecular sciences.
[5] B. Salehi,et al. Ethnobotany of the genus Taraxacum—Phytochemicals and antimicrobial activity , 2018, Phytotherapy research : PTR.
[6] B. Salehi,et al. Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion , 2018, Molecules.
[7] A. Mishra,et al. Satyrium nepalense, a high altitude medicinal orchid of Indian Himalayan region: chemical profile and biological activities of tuber extracts. , 2018, Cellular and molecular biology.
[8] B. Salehi,et al. Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy , 2017, Molecules.
[9] Ziyu Jiang,et al. β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] A. Ramos-Esquivel,et al. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance. , 2017, Journal of oncology practice.
[11] L. Skálová,et al. The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines , 2017, Molecules.
[12] Ray-Jade Chen,et al. Inhibition of NF‐κB and metastasis in irinotecan (CPT‐11)‐resistant LoVo colon cancer cells by thymoquinone via JNK and p38 , 2017, Environmental toxicology.
[13] E. M. Williamson,et al. A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies , 2016, Phytotherapy research : PTR.
[14] Weidong Chen,et al. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. , 2016, European journal of pharmacology.
[15] Rana Khalife,et al. Thymoquinone from Nigella sativa Seeds Promotes the Antitumor Activity of Noncytotoxic Doses of Topotecan in Human Colorectal Cancer Cells in Vitro , 2016, Planta Medica.
[16] A. Mileo,et al. Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies , 2015, Oxidative medicine and cellular longevity.
[17] Lena Jaeger,et al. Concise Dictionary Of Modern Medicine , 2016 .
[18] Banu Iskender,et al. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer , 2016, Tumor Biology.
[19] M. Wink,et al. Cytotoxic potentiation of vinblastine and paclitaxel by L-canavanine in human cervical cancer and hepatocellular carcinoma cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[20] G. D'andrea. Quercetin: A flavonol with multifaceted therapeutic applications? , 2015, Fitoterapia.
[21] Solomon Habtemariam,et al. Genistein and cancer: current status, challenges, and future directions. , 2015, Advances in nutrition.
[22] Mou-Ze Liu,et al. Pharmacogenomics and Herb-Drug Interactions: Merge of Future and Tradition , 2015, Evidence-based complementary and alternative medicine : eCAM.
[23] W. Kuo,et al. Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38. , 2015, Journal of agricultural and food chemistry.
[24] Yan Ding,et al. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. , 2015, International journal of clinical and experimental pathology.
[25] E. Bozkurt,et al. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway , 2015, Clinical and Translational Oncology.
[26] E. Williamson,et al. Cancer Patients at Risk of Herb/Food Supplement–Drug Interactions: A Systematic Review , 2014, Phytotherapy research : PTR.
[27] U. Kadam,et al. Multi-drug therapy in chronic condition multimorbidity: a systematic review. , 2014, Family practice.
[28] Rana Khalife,et al. The anti-proliferative and pro-apoptotic effect of topotecan in combination with thymoquinone in acute myelogenous leukemia , 2014 .
[29] A. Kourounakis,et al. Multi-target drug design approaches for multifactorial diseases: from neurodegenerative to cardiovascular applications. , 2014, Current medicinal chemistry.
[30] A. Mantha,et al. Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View , 2014, BioMed research international.
[31] Chi-Ying F. Huang,et al. Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs. , 2014, The Journal of nutritional biochemistry.
[32] Jun Yu,et al. Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer , 2014, Integrative cancer therapies.
[33] D. Hoskin,et al. Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53 , 2014, Nutrition and cancer.
[34] M. Kamal,et al. Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy , 2014, Evidence-based complementary and alternative medicine : eCAM.
[35] P. Fasinu,et al. Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges. , 2014, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[36] Yan Ma,et al. Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer☆ , 2013, Current therapeutic research, clinical and experimental.
[37] E. Kennelly,et al. Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric. , 2013, Anti-cancer agents in medicinal chemistry.
[38] Marco Pautasso,et al. Ten Simple Rules for Writing a Literature Review , 2013, PLoS Comput. Biol..
[39] H. Tokuda,et al. Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines , 2013, Journal of complementary & integrative medicine.
[40] S. Usha,et al. An ex vivo study of selenium, genistein on the morphological and nuclear changes in anticancer drug-induced apoptosis in human peripheral blood lymphocytes. , 2013, BioFactors.
[41] M. R. Bailey,et al. Ginkgo biloba: indications, mechanisms, and safety. , 2013, The Psychiatric clinics of North America.
[42] Jinshun Zhao,et al. β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells. , 2013, Anticancer research.
[43] G. Eumkeb,et al. Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[44] Wei Zhang,et al. Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis , 2013, PloS one.
[45] V. Butterweck,et al. Pharmacokinetic Evaluation of Visnagin and Ammi visnaga Aqueous Extract after Oral Administration in Rats , 2012, Planta Medica.
[46] D. H. Sweet,et al. Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen). , 2013, Drug metabolism and pharmacokinetics.
[47] A. McLachlan,et al. Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion–Transporting Polypeptides , 2012, Clinical pharmacology and therapeutics.
[48] Jing-Rong Wang,et al. Inhibition of P-Glycoprotein Leads to Improved Oral Bioavailability of Compound K, an Anticancer Metabolite of Red Ginseng Extract Produced by Gut Microflora , 2012, Drug Metabolism and Disposition.
[49] C. Sharma,et al. Concurrent Sulforaphane and Eugenol Induces Differential Effects on Human Cervical Cancer Cells , 2012, Integrative cancer therapies.
[50] O. Obodozie. Pharmacokinetics and Drug Interactions of Herbal Medicines: A Missing Critical Step in the Phytomedicine/Drug Development Process , 2012 .
[51] Shwu-Huey Liu,et al. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. , 2012, Journal of ethnopharmacology.
[52] G. Subramaniam,et al. Assessment of Extracts from Red Yeast Rice for Herb-Drug Interaction by in-vitro and in-vivo assays , 2012, Scientific Reports.
[53] K. Gough,et al. A Potential Drug–Herbal Interaction between Ginkgo biloba and Efavirenz , 2012, Journal of the International Association of Physicians in AIDS Care.
[54] A. Izzo. Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data , 2012, Medical Principles and Practice.
[55] B. Petrovska,et al. Historical review of medicinal plants’ usage , 2012, Pharmacognosy reviews.
[56] Xi-jun Wang,et al. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents. , 2011, Fitoterapia.
[57] R. Roby,et al. Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. , 2011, Biochemical pharmacology.
[58] Chun-song Zheng,et al. Potential synergistic and multitarget effect of herbal pair Chuanxiong Rhizome-Paeonia Albifora Pall on osteoarthritis disease: A computational pharmacology approach , 2011, Chinese journal of integrative medicine.
[59] I. So,et al. Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. , 2011, Biochemical and biophysical research communications.
[60] R. Schobert,et al. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin , 2011, Cancer Chemotherapy and Pharmacology.
[61] H. Glaeser,et al. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. , 2010, Biochemical pharmacology.
[62] S. M. Asdaq,et al. Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[63] W. Rzeski,et al. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. , 2010, Chemico-biological interactions.
[64] O. Obodozie,et al. The influence of Nifadin®, Niprisan® and Niprd/92/001/1-1 (AM-1) on the pharmacokinetics of metronidazole in rats , 2010, European Journal of Drug Metabolism and Pharmacokinetics.
[65] Gangjun Du,et al. Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. , 2010, International immunopharmacology.
[66] P. van Bladeren,et al. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect. , 2010, Toxicology and applied pharmacology.
[67] A. Demiroglu-Zergeroglu,et al. The Investigation of Effects of Quercetin and Its Combination with Cisplatin on Malignant Mesothelioma Cells In Vitro , 2010, Journal of biomedicine & biotechnology.
[68] T. S. Kim,et al. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. , 2010, Biochemical and biophysical research communications.
[69] Y. Sawada,et al. Inhibitory effects of herbal extracts on breast cancer resistance protein (BCRP) and structure-inhibitory potency relationship of isoflavonoids. , 2010, Drug metabolism and pharmacokinetics.
[70] Barbara Bloom,et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. , 2009, National health statistics reports.
[71] M. Maracy,et al. Combined therapy of silymarin and desferrioxamine in patients with β‐thalassemia major: a randomized double‐blind clinical trial , 2009, Fundamental & clinical pharmacology.
[72] Yu-Tang Tung,et al. Protective effect of Acacia confusa bark extract and its active compound gallic acid against carbon tetrachloride-induced chronic liver injury in rats. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[73] A. Bishayee,et al. d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis , 2009, Journal of carcinogenesis.
[74] Lawrence X. Yu,et al. Mechanistic Approaches to Predicting Oral Drug Absorption , 2009, The AAPS Journal.
[75] E. Ragazzi,et al. Cell‐cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells , 2009, Cell proliferation.
[76] M. Doble,et al. Synergism between natural products and antibiotics against infectious diseases. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[77] Hiroshi Suzuki,et al. Inhibitory Effects of Terpenoids on Multidrug Resistance-Associated Protein 2- and Breast Cancer Resistance Protein-Mediated Transport , 2008, Drug Metabolism and Disposition.
[78] A. Pichette,et al. Potentiating effect of β‐caryophyllene on anticancer activity of α‐humulene, isocaryophyllene and paclitaxel , 2007 .
[79] A. Rosato,et al. Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[80] A. Doria,et al. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing’s sarcoma cell lines , 2007, Journal of neurochemistry.
[81] D. Brann,et al. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors , 2007, Journal of neurochemistry.
[82] B. Aggarwal,et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. , 2007, Blood.
[83] A. Pichette,et al. Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. , 2007, The Journal of pharmacy and pharmacology.
[84] P. Imming,et al. Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.
[85] Sanjeev Banerjee,et al. Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts , 2006, Cancer.
[86] George D Geromichalos,et al. Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro. , 2006, Cancer letters.
[87] Liping Jiang,et al. Synergistic Inhibitory Effects of Curcumin and 5-Fluorouracil on the Growth of the Human Colon Cancer Cell Line HT-29 , 2005, Chemotherapy.
[88] Sanjeev Banerjee,et al. Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice , 2005, Clinical Cancer Research.
[89] Zhiwei Wang,et al. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. , 2005, Cancer research.
[90] J. Grutsch,et al. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care , 2005, Supportive Care in Cancer.
[91] R. Day,et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2005, British journal of clinical pharmacology.
[92] W. Jonas. Mosby's dictionary of complementary & alternative medicine , 2005 .
[93] Shufeng Zhou,et al. Pharmacokinetic Interactions of Drugs with St John’s Wort , 2004, Journal of psychopharmacology.
[94] Andreas Rolfs,et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins , 2004, Pflügers Archiv.
[95] Benjamin J. Whalley,et al. Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects? , 2003 .
[96] Min Huang,et al. Interactions of Herbs with Cytochrome P450 , 2003, Drug metabolism reviews.
[97] Takao Yokota,et al. Plant foods and herbal sources of resveratrol. , 2002, Journal of agricultural and food chemistry.
[98] Samir K. Gupta,et al. Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not Desloratadine , 2002, Clinical pharmacokinetics.
[99] Cody Schrank,et al. American Cancer Society , 2005 .
[100] K. Lundstrom,et al. Neurochemical studies with St. John's wort in vitro. , 2001, Pharmacopsychiatry.
[101] P. Chyka,et al. Interactions of Warfarin with Garlic, Ginger, Ginkgo, or Ginseng: Nature of the Evidence , 2000, The Annals of pharmacotherapy.
[102] J. Wang,et al. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. , 2000 .
[103] A. Nahrstedt,et al. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.
[104] Berenbaum Mc. What is synergy? , 1989, Pharmacological reviews.
[105] M. Berenbaum. What is synergy? , 1989, Pharmacological reviews.
[106] T. Chou,et al. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.
[107] M C Berenbaum,et al. Criteria for analyzing interactions between biologically active agents. , 1981, Advances in cancer research.
[108] M C Berenbaum,et al. Synergy, additivism and antagonism in immunosuppression. A critical review. , 1977, Clinical and experimental immunology.
[109] R. Fuller,et al. Operating Manual for Spaceship Earth , 1969 .
[110] John Leyden. Webb,et al. Enzyme and metabolic inhibitors , 1963 .
[111] S. Loewe. The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.